References

Citation 1: http://pubs.acs.org/subscribe/archive/mdd/v04/i04/html/MDD04FeatureVogelson.html

Citation 2: http://medical-dictionary.thefreedictionary.com/drug+delivery

Citation 3: Wang, NX.; von Recum, HA. (2011). "Affinity-Based Drug Delivery". Macromol Biosci 11: 321–332. doi:10.1002/mabi.201000206.

Citation 4: Bertrand N, Leroux JC. (2011). "The journey of a drug carrier in the body: an anatomo-physiological perspective". Journal of Controlled Release.doi:10.1016/j.jconrel.2011.09.098.

Citation 5: http://www.sciencedaily.com/articles/n/nanoparticle.htm

Citation 6: Rainer H. Muller, Karsten Mader and Sven Gohla, Eur. J. Pharm. Biopharm., 50(1), 161-177 (2000).

Citation 7: http://www.sadgurupublications.com/ContentPaper/2012/9_117_SRCC_2(1)2012_P.pdf

Citation 8: http://www.springerreference.com/docs/html/chapterdbid/340087.html

Citation 9: http://www.news-medical.net/health/What-is-a-Liposome.aspx

Citation 10: http://www.slideshare.net/tabirsir/liposomes-improving-drug-delivery

Citation 11: http://www.nanoscalereslett.com/content/8/1/102

Citation 12: http://jddtonline.info/index.php/jddt/article/viewFile/355/345

Citation 13: A. D. Bangham, “Lipid bilayers and biomembranes,” Annual Review of Biochemistry, vol. 41, pp. 753–776, 1972.

Citation 14: G. Sessa and G. Weissmann, “Phospholipid spherules (liposomes) as a model for biological membranes,” Journal of Lipid Research, vol. 9, no. 3, pp. 310–318, 1968.

Citation 15: G. Gregoriadis, P. D. Leathwood, and B. E. Ryman, “Enzyme entrapment in liposomes,” FEBS Letters, vol. 14, no. 2, pp. 95–99, 1971.

Citation 16: Y. E. Rahman, M. W. Rosenthal, E. A. Cerny, and E. S. Moretti, “Preparation and prolonged tissue retention of liposome encapsulated chelating agents,” Journal of Laboratory and Clinical Medicine, vol. 83, no. 4, pp. 640–647, 1974.

Citation 17: D. D. Lasic, “Kinetic and thermodynamic effects on the structure and formation of phosphatidylcholine vesicles,” Hepatology, vol. 13, no. 5, pp. 1010–1012, 1991.

Citation 18: A. S. Ulrich, “Biophysical aspects of using liposomes as delivery vehicles,” Bioscience Reports, vol. 22, no. 2, pp. 129–150, 2002.

Citation 19: http://www.hindawi.com/journals/jdd/2011/591325/#B1

Citation 20: Lichtenberg,D., and Barenholz, Y., 1988. In: Glick, D. (Ed.) Methods of biological analysis, Vol. 33, John Wiley and Sons Inc., New York, pp. 337-461.

Citation 21: Nassander, U.K., Storm, G., Peeters, P.A.M., Crommelin, D.J.A., 1990. Liposomes. In: Chosin, M. and Langer, R., (Eds.), Biodegradeable Polymers as Drug Delivery Systems, Marcel Dekker Inc., New York, pp. 261-338. Citation 22: http://www.pharmatutor.org/articles/liposome-novel-drug-delivery-system?page=0,5 Citation 23: http://ferraralab.bme.ucdavis.edu/research/

Citation 24: http://www.merriam-webster.com/dictionary/exogenous

Citation 25: http://www.northeastern.edu/bouve/news/2012/09/A%20lifetime%20of%20liposomes.html

Citation 26: http://www.northeastern.edu/bouve/news/2012/09/A%20lifetime%20of%20liposomes.html

Citation 27: http://www.chem.purdue.edu/people/faculty/faculty.asp?itemID=63

Citation 28: http://uthscsa.edu/hscnews/singleformat2.asp?newID=4107 Citation 29: http://tulane.edu/sse/cbe/faculty/

Citation 30: https://tulane.edu/som/regenmed/upload/Godbey-Liposome-Review.pdf

Citation 31: http://www.lippomix.com/liposome_patents.asp

Citation 32: http://www.liposomesociety.org/joo/index.php?option=com_content&view=article&id=19&Itemid=27&limitstart=3

Citation 33: http://www.in-pharmatechnologist.com/smartlead/view/250128/4/Genzyme-Pharmaceuticals

Citation 34: http://www.docbrown.info/page03/nanochem07.htm

Citation 35: http://ec.europa.eu/health/scientific_committees/opinions_layman/en/nanotechnologies/l-2/6-health-effects-nanoparticles.htm

Citation 36: http://www.nature.com/nnano/journal/v6/n10/full/nnano.2011.169.html